Autopsy report · NCT00764660
Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)
Cause of deathFutility
“Based on the outcome of a planned interim analysis, the study was stopped early due to futility.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 5 months before it stopped.
- 141 participants enrolled.
- Results were posted on the registry 6 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Alcoholism
- Interventions
- SCH 900435; Placebo
- Participants
- 141
Trials that died the same way
- Tissue Adhesive vs. Sterile Strips After Cesarean Delivery
“Based on results of an interim analysis, the study was halted for futility” - Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients
“The study was stopped for futility at the first interim analysis” - CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)
“Study was terminated after the planned interim analysis as the pre-defined futility threshold was met” - A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
“The study was stopped for futility based on efficacy results at the interim analysis; no unexpected safety findings were observed.” - Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
“This study was terminated early due to futility.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.